Who are we

Fundación CANNA is a non-profit initiative of the CANNA España Fertilizantes SL company, a multi-national company producing high quality fertilizers for fast growing plants.

The Foundation carries out studies and conducts research on Cannabis and its active compounds. Its main focus is on:

  • Cannabis plants and their active compounds, related studies and scientific research, especially regarding its effects on the human body and mind.
  • Scientific research regarding Cannabis use and its derivatives.

Fundación CANNA has a laboratory where different kind of tests are performed.

The idea of the Foundation was conceived out of the need to offer an answer to a broad demand for testing and research.

Fundación CANNA financially supports different congresses, iniciatives and (clinical) studies in order to push forward the knowlegde about cannabinoids as a medicine. Help us to support more studies and clinical trials by becoming a donor!

Board of Scientific Members:

MSc. Iñaki García

Prof. Dr. Kirsten Müller-Vahl

Prof. Manuel Guzmán

Dr. Raquel Peyraube

Susan van Brunschot

MSc. Iñaki García

Iñaki García. Technical Agricultural Engineer and Graduate in Biotechnology. Working since 1999 in the cannabis industry. He has worked as an adviser on the use and development of fertilisers and additives for cannabis and currently holds the post of technical and scientific director at the laboratory run by the Fundación Canna.

During his time with the Foundation, he has developed analytical methods for quantifying cannabinoids and terpenes in different cannabis-based products and has designed and performed various studies related to the quality of these products.

His passion for the plant led him to study genetic plant improvement and his master's dissertation was on analytical methods applied to the improvement of cannabis.

Prof. Dr. Kirsten Müller-Vahl

Dr. Kirsten R. Müller-Vahl is a Professor of Psychiatry at the Department of Psychiatry, Socialpsychiatry and Psychotherapy at the Hannover Medical School (MHH), Germany. She is a specialist in both neurology and adult psychiatry. From 1997 to 2003 she was a grant holder of the German government (Dorothea-Erxleben-Stipendium) for scientific research related to Tourette syndrome (TS).

During the last 20 years she has investigated more than 1500 patients with TS (children and adults) and is the head of the Tourette-Syndrome outpatient department (since 1995). From, 2012-2016 she was the vice president of the European Society of the study of Tourette syndrome (ESSTS). She was a German representative of the COST Action BM0905 (“European Network for the Study of Gilles de la Tourette Syndrome”). She is a full partner and a working group leader in the EU funded programmes “European Multicentre Tics in Children Studies” (EMTICS) and “TS-EUROTRAIN-Interdisciplinary training network for Tourette Syndrome”. She is a member of the Medical Advisory Board of the Tourette Association of America (TAA) and an author of the guidelines for the treatment of TS of both ESSTS and the American Academy of Neurology.

Since 1998, she is a member and 2. Chairwoman of the Association for Cannabinoid Medicines (ACM). She was a founding member of the International Association for Cannabinoid Medicines (IACM) and from 2007-2009 1. Chairwoman and since 2015 vice president of the IACM.

Prof. Manuel Guzmán

Manuel Guzmán is Professor of Biochemistry and Molecular Biology at Complutense University of Madrid, member of the Spanish Royal Academy of Pharmacy, and member of the Board of Directors of the International Association for Cannabinoid Medicines. His research focuses on the study of the mechanism of action and therapeutic properties of cannabinoids, especially in the nervous system.

This work has given rise to more than one hundred publications in specialized international journals, as well as to several international patents on the possible therapeutic applications of cannabinoids as anticancer and neuroprotective drugs. He routinely collaborates with scientific reviewing and funding agencies.

Dr. Raquel Peyraube

Raquel Peyraube is a doctor in medicine and a specialist in the problematic use of drugs. She has trained in psychiatry, toxicology and psychoanalytical psychotherapy and in subjects such as childhood, adolescence and social exclusion. She has 28 years' experience in the field. Throughout her career, she has made contributions in training, prevention, treatment and damage reduction, including innovating theoretical and methodological developments with emphasis on ethical issues.

As a former clinical director of ICEERS, she is now an ad hoc consultant of the Uruguayan National Drugs Secretariat giving advice on reform of the public drugs policy and of the Institute of Cannabis Regulation and Control. She is a clinical researcher and a member of research teams for monitoring the law in Uruguay. She sits on several international scientific committees and is an active member of the IACM (International Association for Cannabinoid Medicines).

She currently works on the development of clinical trials, medical education on medicinal cannabis, and dissemination of information and advice for reform of drugs policies in various countries.

Susan van Brunschot

In 2011 Susan van Brunschot had the idea to create a non profit foundation aimed to study the Cannabis plant and its deratives as well as educating the general public about Cannabis.

Susan already worked for 7 years as the CEO of CANNA Espana Fertilizantes SL. The CANNA company was delighted about the idea and as a result Fundación CANNA was born. Susan studied International Business at the University of Amsterdam (Hogeschool Holland, 2000).

Within Fundación CANNA she is mainly responsible for strategic growth and further expansion of education to a broader public.